Hence, increased Fgf23 could be a major factor contributing to disease progression post‐MI by 1) volume overload through stimulation of renal NCC expression; 2) induction of endothelial dysfunction through suppression of vitamin D hormone production; and 3) possibly direct pro‐hypertrophic actions on the heart. Here, SLC12A3 is linked to endothelial dysfunction.